Alt text
Alt text

Clinical trial results for
advanced liver cancer

See results for OPDIVO immunotherapy in combination with YERVOY for adults with liver cancer (hepatocellular carcinoma)

Actor portrayals.

Previously untreated advanced liver cancer

OPDIVO + YERVOY

For adults with a type of liver cancer called hepatocellular carcinoma that cannot be removed by surgery or has spread

Previously treated advanced liver cancer

OPDIVO + YERVOY

For adults with a type of liver cancer called hepatocellular carcinoma when your liver cancer cannot be removed by surgery or has spread, and you have received prior treatment with sorafenib

OPDIVO will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion



7356-US-2500069  04/25